ClinicalTrials.gov
public full text
Public Domain
CA-125 in Screening Patients at High Risk for Ovarian Cancer
RATIONALE: Measuring levels of CA 125 in blood samples of women who have a high risk of developing ovarian cancer may help doctors detect cancer early and plan more effective treatment. PURPOSE: This phase II trial is studying CA-125 levels in screening for cancer in women who are at high risk of developing ovarian cancer.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Use of CA125 and Complementary Biomarkers for the Early Detection of Ovarian Cancer in Low Risk Women#897736
- Are CK+/CD45+ Double-Positive Circulating Cells of Tumor-origin? Characterization in METAstatic Breast Cancer#1174057
- Feasibility of a New Technology for Isolating Circulating Tumour Cells#884624
- A Cohort of Molecular Characteristics and Prognosis of Colorectal Cancer#857704
- Studying Biomarkers in Blood Samples From Patients With Invasive Cervical Cancer#913389
Record · ID 848802
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive